Neurodegenerative diseases (NDs) including Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD), amongst others, pose significant challenges in terms of brain targeted drug delivery. The blood-brain barrier (BBB) limits the passage of substance into the brain including potential therapeutics, hence hindering their efficacy in treating NDs. Nanoparticles are promising carriers for brain targeted drug delivery as result of their design with potential to bypass the BBB. These nanoparticles are made from natural (organic) and artificial (inorganic) manipulations of substances such as metal, carbon-based materials, liposomal, polymeric, proteins, polysaccharides fullerenes, nanoemulsions, coffee, chitosan etc. Nanoparticles are engineered to encapsulate drugs thereby protecting, controlled release, and enhanced drug stability in addition to its surface modifications with ligands that facilitate receptor- driven transport across the BBB, promoting targeted drug passage to specific regions of the brain by neurodegenerative disorders. Furthermore, nanoparticles even though are small sized, they have versatile therapeutics, that enables the delivery of different types of drugs with potential neuroprotective, anti-inflammatory, or neurodegenerative properties, addressing the multifactorial nature of neurodegenerative disorders. In this chapter, we discuss nanoparticles therapeutics in NDs, their characteristics, mechanisms through which they can be used to target brain regions as well as reported therapeutics applications to specific NDs including AD, PD, HD, Prion disease, Multiple Sclerosis (MS) and Amyotrophic Lateral Sclerosis. <!----> <!----> <!----> <!---->